Rapid Micro Biosystems, Inc. (RPID) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Rapid Micro Biosystems, Inc. on May 21, 2026. The company is incorporated in Delaware and its Class A Common Stock trades on the Nasdaq Capital Market under the symbol RPID.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Two primary matters were voted upon by stockholders:
- Director Election: Richard Kollender was elected as a Class II Director to serve until the 2029 Annual Meeting.
- Total shares eligible to vote: 41,267,511
- Shares present in person or by proxy: 37,099,555
- Votes For: 23,180,585
- Votes Withheld: 1,998,525
- Broker Non-Votes: 11,920,445
- Auditor Ratification: Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes For: 37,096,030
- Votes Against: 3,292
- Votes Abstaining: 233
- Broker Non-Votes: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The report is limited to the disclosure of the Annual Meeting outcomes.
Key Facts for Investor Verification
- Richard Kollender's tenure as a Class II Director extends through the 2029 Annual Meeting.
- PricewaterhouseCoopers LLP has been ratified as the auditor for the fiscal year ending December 31, 2026.
- Approximately 89.9% of eligible shares were present or represented by proxy at the meeting.
- Broker non-votes constituted a significant portion (approx. 29%) of the eligible shares for the director election but were zero for the auditor ratification.